nodes	percent_of_prediction	percent_of_DWPC	metapath
Oritavancin—Hyperuricaemia—Methotrexate—systemic lupus erythematosus	0.00519	0.00519	CcSEcCtD
Oritavancin—Immune system disorder—Leflunomide—systemic lupus erythematosus	0.00512	0.00512	CcSEcCtD
Oritavancin—Mediastinal disorder—Leflunomide—systemic lupus erythematosus	0.00511	0.00511	CcSEcCtD
Oritavancin—Alanine aminotransferase increased—Hydrocortisone—systemic lupus erythematosus	0.00496	0.00496	CcSEcCtD
Oritavancin—Malnutrition—Leflunomide—systemic lupus erythematosus	0.00493	0.00493	CcSEcCtD
Oritavancin—Blood uric acid increased—Methotrexate—systemic lupus erythematosus	0.0049	0.0049	CcSEcCtD
Oritavancin—Infestation NOS—Cyclosporine—systemic lupus erythematosus	0.00487	0.00487	CcSEcCtD
Oritavancin—Infestation—Cyclosporine—systemic lupus erythematosus	0.00487	0.00487	CcSEcCtD
Oritavancin—Anaemia—Azathioprine—systemic lupus erythematosus	0.00483	0.00483	CcSEcCtD
Oritavancin—Vomiting—Dapsone—systemic lupus erythematosus	0.0048	0.0048	CcSEcCtD
Oritavancin—Infestation NOS—Mycophenolate mofetil—systemic lupus erythematosus	0.00475	0.00475	CcSEcCtD
Oritavancin—Infestation—Mycophenolate mofetil—systemic lupus erythematosus	0.00475	0.00475	CcSEcCtD
Oritavancin—Headache—Dapsone—systemic lupus erythematosus	0.00472	0.00472	CcSEcCtD
Oritavancin—Alanine aminotransferase increased—Methylprednisolone—systemic lupus erythematosus	0.00466	0.00466	CcSEcCtD
Oritavancin—Anaemia—Leflunomide—systemic lupus erythematosus	0.00456	0.00456	CcSEcCtD
Oritavancin—Angioedema—Leflunomide—systemic lupus erythematosus	0.00451	0.00451	CcSEcCtD
Oritavancin—Bronchospasm—Methylprednisolone—systemic lupus erythematosus	0.00449	0.00449	CcSEcCtD
Oritavancin—Nausea—Dapsone—systemic lupus erythematosus	0.00448	0.00448	CcSEcCtD
Oritavancin—Myalgia—Azathioprine—systemic lupus erythematosus	0.00445	0.00445	CcSEcCtD
Oritavancin—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—systemic lupus erythematosus	0.00442	0.00442	CcSEcCtD
Oritavancin—Infestation NOS—Hydrocortisone—systemic lupus erythematosus	0.00433	0.00433	CcSEcCtD
Oritavancin—Infestation—Hydrocortisone—systemic lupus erythematosus	0.00433	0.00433	CcSEcCtD
Oritavancin—Connective tissue disorder—Cyclosporine—systemic lupus erythematosus	0.0043	0.0043	CcSEcCtD
Oritavancin—Infection—Azathioprine—systemic lupus erythematosus	0.00424	0.00424	CcSEcCtD
Oritavancin—Oedema peripheral—Mycophenolate mofetil—systemic lupus erythematosus	0.0042	0.0042	CcSEcCtD
Oritavancin—Myalgia—Leflunomide—systemic lupus erythematosus	0.0042	0.0042	CcSEcCtD
Oritavancin—Connective tissue disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.00419	0.00419	CcSEcCtD
Oritavancin—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic lupus erythematosus	0.00417	0.00417	CcSEcCtD
Oritavancin—Skin disorder—Azathioprine—systemic lupus erythematosus	0.00414	0.00414	CcSEcCtD
Oritavancin—Infestation—Methylprednisolone—systemic lupus erythematosus	0.00407	0.00407	CcSEcCtD
Oritavancin—Infestation NOS—Methylprednisolone—systemic lupus erythematosus	0.00407	0.00407	CcSEcCtD
Oritavancin—Infection—Leflunomide—systemic lupus erythematosus	0.004	0.004	CcSEcCtD
Oritavancin—Cardiac disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.00396	0.00396	CcSEcCtD
Oritavancin—Nervous system disorder—Leflunomide—systemic lupus erythematosus	0.00395	0.00395	CcSEcCtD
Oritavancin—Mediastinal disorder—Cyclosporine—systemic lupus erythematosus	0.00394	0.00394	CcSEcCtD
Oritavancin—Tachycardia—Leflunomide—systemic lupus erythematosus	0.00393	0.00393	CcSEcCtD
Oritavancin—Skin disorder—Leflunomide—systemic lupus erythematosus	0.00391	0.00391	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Azathioprine—systemic lupus erythematosus	0.00389	0.00389	CcSEcCtD
Oritavancin—Mediastinal disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.00385	0.00385	CcSEcCtD
Oritavancin—Connective tissue disorder—Hydrocortisone—systemic lupus erythematosus	0.00382	0.00382	CcSEcCtD
Oritavancin—Malnutrition—Cyclosporine—systemic lupus erythematosus	0.00381	0.00381	CcSEcCtD
Oritavancin—Malnutrition—Mycophenolate mofetil—systemic lupus erythematosus	0.00371	0.00371	CcSEcCtD
Oritavancin—Alanine aminotransferase increased—Prednisone—systemic lupus erythematosus	0.00369	0.00369	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Azathioprine—systemic lupus erythematosus	0.00368	0.00368	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Leflunomide—systemic lupus erythematosus	0.00367	0.00367	CcSEcCtD
Oritavancin—Connective tissue disorder—Methylprednisolone—systemic lupus erythematosus	0.00359	0.00359	CcSEcCtD
Oritavancin—Anaemia—Cyclosporine—systemic lupus erythematosus	0.00352	0.00352	CcSEcCtD
Oritavancin—Immune system disorder—Hydrocortisone—systemic lupus erythematosus	0.00351	0.00351	CcSEcCtD
Oritavancin—Angioedema—Cyclosporine—systemic lupus erythematosus	0.00348	0.00348	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Leflunomide—systemic lupus erythematosus	0.00348	0.00348	CcSEcCtD
Oritavancin—Anaemia—Mycophenolate mofetil—systemic lupus erythematosus	0.00343	0.00343	CcSEcCtD
Oritavancin—Angioedema—Mycophenolate mofetil—systemic lupus erythematosus	0.00339	0.00339	CcSEcCtD
Oritavancin—Cardiac disorder—Methylprednisolone—systemic lupus erythematosus	0.00339	0.00339	CcSEcCtD
Oritavancin—Malnutrition—Hydrocortisone—systemic lupus erythematosus	0.00338	0.00338	CcSEcCtD
Oritavancin—Immune system disorder—Methylprednisolone—systemic lupus erythematosus	0.0033	0.0033	CcSEcCtD
Oritavancin—Mediastinal disorder—Methylprednisolone—systemic lupus erythematosus	0.00329	0.00329	CcSEcCtD
Oritavancin—Myalgia—Cyclosporine—systemic lupus erythematosus	0.00324	0.00324	CcSEcCtD
Oritavancin—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—systemic lupus erythematosus	0.00322	0.00322	CcSEcCtD
Oritavancin—Urticaria—Leflunomide—systemic lupus erythematosus	0.0032	0.0032	CcSEcCtD
Oritavancin—Malnutrition—Methylprednisolone—systemic lupus erythematosus	0.00318	0.00318	CcSEcCtD
Oritavancin—Angioedema—Prednisolone—systemic lupus erythematosus	0.00317	0.00317	CcSEcCtD
Oritavancin—Myalgia—Mycophenolate mofetil—systemic lupus erythematosus	0.00316	0.00316	CcSEcCtD
Oritavancin—Hypersensitivity—Azathioprine—systemic lupus erythematosus	0.00314	0.00314	CcSEcCtD
Oritavancin—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic lupus erythematosus	0.00314	0.00314	CcSEcCtD
Oritavancin—Angioedema—Hydrocortisone—systemic lupus erythematosus	0.00309	0.00309	CcSEcCtD
Oritavancin—Infection—Cyclosporine—systemic lupus erythematosus	0.00309	0.00309	CcSEcCtD
Oritavancin—Nervous system disorder—Cyclosporine—systemic lupus erythematosus	0.00305	0.00305	CcSEcCtD
Oritavancin—Skin disorder—Cyclosporine—systemic lupus erythematosus	0.00302	0.00302	CcSEcCtD
Oritavancin—Infection—Mycophenolate mofetil—systemic lupus erythematosus	0.00301	0.00301	CcSEcCtD
Oritavancin—Eosinophilia—Methotrexate—systemic lupus erythematosus	0.00299	0.00299	CcSEcCtD
Oritavancin—Nervous system disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.00297	0.00297	CcSEcCtD
Oritavancin—Hypersensitivity—Leflunomide—systemic lupus erythematosus	0.00297	0.00297	CcSEcCtD
Oritavancin—Tachycardia—Mycophenolate mofetil—systemic lupus erythematosus	0.00296	0.00296	CcSEcCtD
Oritavancin—Skin disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.00295	0.00295	CcSEcCtD
Oritavancin—Diarrhoea—Azathioprine—systemic lupus erythematosus	0.00292	0.00292	CcSEcCtD
Oritavancin—Angioedema—Triamcinolone—systemic lupus erythematosus	0.00291	0.00291	CcSEcCtD
Oritavancin—Angioedema—Methylprednisolone—systemic lupus erythematosus	0.00291	0.00291	CcSEcCtD
Oritavancin—Myalgia—Hydrocortisone—systemic lupus erythematosus	0.00288	0.00288	CcSEcCtD
Oritavancin—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—systemic lupus erythematosus	0.00286	0.00286	CcSEcCtD
Oritavancin—Pruritus—Leflunomide—systemic lupus erythematosus	0.00285	0.00285	CcSEcCtD
Oritavancin—Connective tissue disorder—Prednisone—systemic lupus erythematosus	0.00284	0.00284	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Cyclosporine—systemic lupus erythematosus	0.00283	0.00283	CcSEcCtD
Oritavancin—Dizziness—Azathioprine—systemic lupus erythematosus	0.00282	0.00282	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Mycophenolate mofetil—systemic lupus erythematosus	0.00276	0.00276	CcSEcCtD
Oritavancin—Tachycardia—Prednisolone—systemic lupus erythematosus	0.00276	0.00276	CcSEcCtD
Oritavancin—Diarrhoea—Leflunomide—systemic lupus erythematosus	0.00276	0.00276	CcSEcCtD
Oritavancin—Infection—Hydrocortisone—systemic lupus erythematosus	0.00274	0.00274	CcSEcCtD
Oritavancin—Myalgia—Triamcinolone—systemic lupus erythematosus	0.00271	0.00271	CcSEcCtD
Oritavancin—Vomiting—Azathioprine—systemic lupus erythematosus	0.00271	0.00271	CcSEcCtD
Oritavancin—Nervous system disorder—Hydrocortisone—systemic lupus erythematosus	0.00271	0.00271	CcSEcCtD
Oritavancin—Myalgia—Methylprednisolone—systemic lupus erythematosus	0.00271	0.00271	CcSEcCtD
Oritavancin—Tachycardia—Hydrocortisone—systemic lupus erythematosus	0.0027	0.0027	CcSEcCtD
Oritavancin—Infestation—Methotrexate—systemic lupus erythematosus	0.00269	0.00269	CcSEcCtD
Oritavancin—Infestation NOS—Methotrexate—systemic lupus erythematosus	0.00269	0.00269	CcSEcCtD
Oritavancin—Rash—Azathioprine—systemic lupus erythematosus	0.00269	0.00269	CcSEcCtD
Oritavancin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—systemic lupus erythematosus	0.00269	0.00269	CcSEcCtD
Oritavancin—Dermatitis—Azathioprine—systemic lupus erythematosus	0.00269	0.00269	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Cyclosporine—systemic lupus erythematosus	0.00268	0.00268	CcSEcCtD
Oritavancin—Skin disorder—Hydrocortisone—systemic lupus erythematosus	0.00268	0.00268	CcSEcCtD
Oritavancin—Headache—Azathioprine—systemic lupus erythematosus	0.00267	0.00267	CcSEcCtD
Oritavancin—Dizziness—Leflunomide—systemic lupus erythematosus	0.00266	0.00266	CcSEcCtD
Oritavancin—Angioedema—Dexamethasone—systemic lupus erythematosus	0.00264	0.00264	CcSEcCtD
Oritavancin—Angioedema—Betamethasone—systemic lupus erythematosus	0.00264	0.00264	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.00262	0.00262	CcSEcCtD
Oritavancin—Immune system disorder—Prednisone—systemic lupus erythematosus	0.00261	0.00261	CcSEcCtD
Oritavancin—Infection—Triamcinolone—systemic lupus erythematosus	0.00258	0.00258	CcSEcCtD
Oritavancin—Infection—Methylprednisolone—systemic lupus erythematosus	0.00258	0.00258	CcSEcCtD
Oritavancin—Vomiting—Leflunomide—systemic lupus erythematosus	0.00256	0.00256	CcSEcCtD
Oritavancin—Nervous system disorder—Methylprednisolone—systemic lupus erythematosus	0.00254	0.00254	CcSEcCtD
Oritavancin—Rash—Leflunomide—systemic lupus erythematosus	0.00254	0.00254	CcSEcCtD
Oritavancin—Tachycardia—Triamcinolone—systemic lupus erythematosus	0.00254	0.00254	CcSEcCtD
Oritavancin—Dermatitis—Leflunomide—systemic lupus erythematosus	0.00254	0.00254	CcSEcCtD
Oritavancin—Nausea—Azathioprine—systemic lupus erythematosus	0.00253	0.00253	CcSEcCtD
Oritavancin—Tachycardia—Methylprednisolone—systemic lupus erythematosus	0.00253	0.00253	CcSEcCtD
Oritavancin—Headache—Leflunomide—systemic lupus erythematosus	0.00252	0.00252	CcSEcCtD
Oritavancin—Skin disorder—Methylprednisolone—systemic lupus erythematosus	0.00252	0.00252	CcSEcCtD
Oritavancin—Malnutrition—Prednisone—systemic lupus erythematosus	0.00252	0.00252	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Hydrocortisone—systemic lupus erythematosus	0.00252	0.00252	CcSEcCtD
Oritavancin—Urticaria—Cyclosporine—systemic lupus erythematosus	0.00247	0.00247	CcSEcCtD
Oritavancin—Myalgia—Dexamethasone—systemic lupus erythematosus	0.00246	0.00246	CcSEcCtD
Oritavancin—Myalgia—Betamethasone—systemic lupus erythematosus	0.00246	0.00246	CcSEcCtD
Oritavancin—Urticaria—Mycophenolate mofetil—systemic lupus erythematosus	0.00241	0.00241	CcSEcCtD
Oritavancin—Nausea—Leflunomide—systemic lupus erythematosus	0.00239	0.00239	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	0.00238	0.00238	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	0.00237	0.00237	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	0.00236	0.00236	CcSEcCtD
Oritavancin—Infection—Betamethasone—systemic lupus erythematosus	0.00234	0.00234	CcSEcCtD
Oritavancin—Infection—Dexamethasone—systemic lupus erythematosus	0.00234	0.00234	CcSEcCtD
Oritavancin—Anaemia—Prednisone—systemic lupus erythematosus	0.00233	0.00233	CcSEcCtD
Oritavancin—Nervous system disorder—Betamethasone—systemic lupus erythematosus	0.00231	0.00231	CcSEcCtD
Oritavancin—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	0.00231	0.00231	CcSEcCtD
Oritavancin—Tachycardia—Betamethasone—systemic lupus erythematosus	0.0023	0.0023	CcSEcCtD
Oritavancin—Tachycardia—Dexamethasone—systemic lupus erythematosus	0.0023	0.0023	CcSEcCtD
Oritavancin—Angioedema—Prednisone—systemic lupus erythematosus	0.0023	0.0023	CcSEcCtD
Oritavancin—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	0.00229	0.00229	CcSEcCtD
Oritavancin—Erythema multiforme—Methotrexate—systemic lupus erythematosus	0.00229	0.00229	CcSEcCtD
Oritavancin—Urticaria—Prednisolone—systemic lupus erythematosus	0.00225	0.00225	CcSEcCtD
Oritavancin—Cardiac disorder—Methotrexate—systemic lupus erythematosus	0.00224	0.00224	CcSEcCtD
Oritavancin—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	0.00223	0.00223	CcSEcCtD
Oritavancin—Pruritus—Cyclosporine—systemic lupus erythematosus	0.0022	0.0022	CcSEcCtD
Oritavancin—Urticaria—Hydrocortisone—systemic lupus erythematosus	0.00219	0.00219	CcSEcCtD
Oritavancin—Immune system disorder—Methotrexate—systemic lupus erythematosus	0.00218	0.00218	CcSEcCtD
Oritavancin—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	0.00218	0.00218	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	0.00215	0.00215	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	0.00215	0.00215	CcSEcCtD
Oritavancin—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	0.00215	0.00215	CcSEcCtD
Oritavancin—Myalgia—Prednisone—systemic lupus erythematosus	0.00214	0.00214	CcSEcCtD
Oritavancin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	0.00213	0.00213	CcSEcCtD
Oritavancin—Diarrhoea—Cyclosporine—systemic lupus erythematosus	0.00213	0.00213	CcSEcCtD
Oritavancin—Malnutrition—Methotrexate—systemic lupus erythematosus	0.0021	0.0021	CcSEcCtD
Oritavancin—Hypersensitivity—Prednisolone—systemic lupus erythematosus	0.00208	0.00208	CcSEcCtD
Oritavancin—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	0.00207	0.00207	CcSEcCtD
Oritavancin—Urticaria—Triamcinolone—systemic lupus erythematosus	0.00207	0.00207	CcSEcCtD
Oritavancin—Urticaria—Methylprednisolone—systemic lupus erythematosus	0.00206	0.00206	CcSEcCtD
Oritavancin—Dizziness—Cyclosporine—systemic lupus erythematosus	0.00206	0.00206	CcSEcCtD
Oritavancin—Infection—Prednisone—systemic lupus erythematosus	0.00204	0.00204	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	0.00204	0.00204	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	0.00204	0.00204	CcSEcCtD
Oritavancin—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	0.00204	0.00204	CcSEcCtD
Oritavancin—Nervous system disorder—Prednisone—systemic lupus erythematosus	0.00202	0.00202	CcSEcCtD
Oritavancin—Tachycardia—Prednisone—systemic lupus erythematosus	0.00201	0.00201	CcSEcCtD
Oritavancin—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	0.002	0.002	CcSEcCtD
Oritavancin—Skin disorder—Prednisone—systemic lupus erythematosus	0.002	0.002	CcSEcCtD
Oritavancin—Vomiting—Cyclosporine—systemic lupus erythematosus	0.00198	0.00198	CcSEcCtD
Oritavancin—Rash—Cyclosporine—systemic lupus erythematosus	0.00196	0.00196	CcSEcCtD
Oritavancin—Dermatitis—Cyclosporine—systemic lupus erythematosus	0.00196	0.00196	CcSEcCtD
Oritavancin—Pruritus—Hydrocortisone—systemic lupus erythematosus	0.00195	0.00195	CcSEcCtD
Oritavancin—Headache—Cyclosporine—systemic lupus erythematosus	0.00195	0.00195	CcSEcCtD
Oritavancin—Anaemia—Methotrexate—systemic lupus erythematosus	0.00195	0.00195	CcSEcCtD
Oritavancin—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	0.00193	0.00193	CcSEcCtD
Oritavancin—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	0.00192	0.00192	CcSEcCtD
Oritavancin—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	0.00191	0.00191	CcSEcCtD
Oritavancin—Rash—Mycophenolate mofetil—systemic lupus erythematosus	0.00191	0.00191	CcSEcCtD
Oritavancin—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	0.00191	0.00191	CcSEcCtD
Oritavancin—Headache—Mycophenolate mofetil—systemic lupus erythematosus	0.0019	0.0019	CcSEcCtD
Oritavancin—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	0.00189	0.00189	CcSEcCtD
Oritavancin—Urticaria—Dexamethasone—systemic lupus erythematosus	0.00187	0.00187	CcSEcCtD
Oritavancin—Urticaria—Betamethasone—systemic lupus erythematosus	0.00187	0.00187	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	0.00187	0.00187	CcSEcCtD
Oritavancin—Dizziness—Prednisolone—systemic lupus erythematosus	0.00187	0.00187	CcSEcCtD
Oritavancin—Nausea—Cyclosporine—systemic lupus erythematosus	0.00185	0.00185	CcSEcCtD
Oritavancin—Pruritus—Triamcinolone—systemic lupus erythematosus	0.00184	0.00184	CcSEcCtD
Oritavancin—Pruritus—Methylprednisolone—systemic lupus erythematosus	0.00184	0.00184	CcSEcCtD
Oritavancin—Dizziness—Hydrocortisone—systemic lupus erythematosus	0.00183	0.00183	CcSEcCtD
Oritavancin—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	0.0018	0.0018	CcSEcCtD
Oritavancin—Myalgia—Methotrexate—systemic lupus erythematosus	0.00179	0.00179	CcSEcCtD
Oritavancin—Rash—Prednisolone—systemic lupus erythematosus	0.00178	0.00178	CcSEcCtD
Oritavancin—Dermatitis—Prednisolone—systemic lupus erythematosus	0.00178	0.00178	CcSEcCtD
Oritavancin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	0.00178	0.00178	CcSEcCtD
Oritavancin—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	0.00178	0.00178	CcSEcCtD
Oritavancin—Headache—Prednisolone—systemic lupus erythematosus	0.00177	0.00177	CcSEcCtD
Oritavancin—Vomiting—Hydrocortisone—systemic lupus erythematosus	0.00176	0.00176	CcSEcCtD
Oritavancin—Rash—Hydrocortisone—systemic lupus erythematosus	0.00174	0.00174	CcSEcCtD
Oritavancin—Dermatitis—Hydrocortisone—systemic lupus erythematosus	0.00174	0.00174	CcSEcCtD
Oritavancin—Headache—Hydrocortisone—systemic lupus erythematosus	0.00173	0.00173	CcSEcCtD
Oritavancin—Dizziness—Triamcinolone—systemic lupus erythematosus	0.00172	0.00172	CcSEcCtD
Oritavancin—Dizziness—Methylprednisolone—systemic lupus erythematosus	0.00172	0.00172	CcSEcCtD
Oritavancin—Infection—Methotrexate—systemic lupus erythematosus	0.00171	0.00171	CcSEcCtD
Oritavancin—Nervous system disorder—Methotrexate—systemic lupus erythematosus	0.00168	0.00168	CcSEcCtD
Oritavancin—Nausea—Prednisolone—systemic lupus erythematosus	0.00168	0.00168	CcSEcCtD
Oritavancin—Pruritus—Betamethasone—systemic lupus erythematosus	0.00167	0.00167	CcSEcCtD
Oritavancin—Pruritus—Dexamethasone—systemic lupus erythematosus	0.00167	0.00167	CcSEcCtD
Oritavancin—Skin disorder—Methotrexate—systemic lupus erythematosus	0.00167	0.00167	CcSEcCtD
Oritavancin—Vomiting—Triamcinolone—systemic lupus erythematosus	0.00165	0.00165	CcSEcCtD
Oritavancin—Vomiting—Methylprednisolone—systemic lupus erythematosus	0.00165	0.00165	CcSEcCtD
Oritavancin—Nausea—Hydrocortisone—systemic lupus erythematosus	0.00164	0.00164	CcSEcCtD
Oritavancin—Rash—Triamcinolone—systemic lupus erythematosus	0.00164	0.00164	CcSEcCtD
Oritavancin—Dermatitis—Triamcinolone—systemic lupus erythematosus	0.00164	0.00164	CcSEcCtD
Oritavancin—Rash—Methylprednisolone—systemic lupus erythematosus	0.00164	0.00164	CcSEcCtD
Oritavancin—Dermatitis—Methylprednisolone—systemic lupus erythematosus	0.00163	0.00163	CcSEcCtD
Oritavancin—Urticaria—Prednisone—systemic lupus erythematosus	0.00163	0.00163	CcSEcCtD
Oritavancin—Headache—Triamcinolone—systemic lupus erythematosus	0.00163	0.00163	CcSEcCtD
Oritavancin—Headache—Methylprednisolone—systemic lupus erythematosus	0.00163	0.00163	CcSEcCtD
Oritavancin—Diarrhoea—Dexamethasone—systemic lupus erythematosus	0.00161	0.00161	CcSEcCtD
Oritavancin—Diarrhoea—Betamethasone—systemic lupus erythematosus	0.00161	0.00161	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	0.00156	0.00156	CcSEcCtD
Oritavancin—Dizziness—Dexamethasone—systemic lupus erythematosus	0.00156	0.00156	CcSEcCtD
Oritavancin—Dizziness—Betamethasone—systemic lupus erythematosus	0.00156	0.00156	CcSEcCtD
Oritavancin—Nausea—Triamcinolone—systemic lupus erythematosus	0.00154	0.00154	CcSEcCtD
Oritavancin—Nausea—Methylprednisolone—systemic lupus erythematosus	0.00154	0.00154	CcSEcCtD
Oritavancin—Hypersensitivity—Prednisone—systemic lupus erythematosus	0.00151	0.00151	CcSEcCtD
Oritavancin—Vomiting—Dexamethasone—systemic lupus erythematosus	0.0015	0.0015	CcSEcCtD
Oritavancin—Vomiting—Betamethasone—systemic lupus erythematosus	0.0015	0.0015	CcSEcCtD
Oritavancin—Rash—Dexamethasone—systemic lupus erythematosus	0.00149	0.00149	CcSEcCtD
Oritavancin—Rash—Betamethasone—systemic lupus erythematosus	0.00149	0.00149	CcSEcCtD
Oritavancin—Dermatitis—Dexamethasone—systemic lupus erythematosus	0.00149	0.00149	CcSEcCtD
Oritavancin—Dermatitis—Betamethasone—systemic lupus erythematosus	0.00149	0.00149	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	0.00148	0.00148	CcSEcCtD
Oritavancin—Headache—Betamethasone—systemic lupus erythematosus	0.00148	0.00148	CcSEcCtD
Oritavancin—Headache—Dexamethasone—systemic lupus erythematosus	0.00148	0.00148	CcSEcCtD
Oritavancin—Pruritus—Prednisone—systemic lupus erythematosus	0.00145	0.00145	CcSEcCtD
Oritavancin—Diarrhoea—Prednisone—systemic lupus erythematosus	0.00141	0.00141	CcSEcCtD
Oritavancin—Nausea—Dexamethasone—systemic lupus erythematosus	0.0014	0.0014	CcSEcCtD
Oritavancin—Nausea—Betamethasone—systemic lupus erythematosus	0.0014	0.0014	CcSEcCtD
Oritavancin—Urticaria—Methotrexate—systemic lupus erythematosus	0.00136	0.00136	CcSEcCtD
Oritavancin—Dizziness—Prednisone—systemic lupus erythematosus	0.00136	0.00136	CcSEcCtD
Oritavancin—Vomiting—Prednisone—systemic lupus erythematosus	0.00131	0.00131	CcSEcCtD
Oritavancin—Rash—Prednisone—systemic lupus erythematosus	0.0013	0.0013	CcSEcCtD
Oritavancin—Dermatitis—Prednisone—systemic lupus erythematosus	0.00129	0.00129	CcSEcCtD
Oritavancin—Headache—Prednisone—systemic lupus erythematosus	0.00129	0.00129	CcSEcCtD
Oritavancin—Hypersensitivity—Methotrexate—systemic lupus erythematosus	0.00127	0.00127	CcSEcCtD
Oritavancin—Nausea—Prednisone—systemic lupus erythematosus	0.00122	0.00122	CcSEcCtD
Oritavancin—Pruritus—Methotrexate—systemic lupus erythematosus	0.00122	0.00122	CcSEcCtD
Oritavancin—Diarrhoea—Methotrexate—systemic lupus erythematosus	0.00118	0.00118	CcSEcCtD
Oritavancin—Dizziness—Methotrexate—systemic lupus erythematosus	0.00114	0.00114	CcSEcCtD
Oritavancin—Vomiting—Methotrexate—systemic lupus erythematosus	0.00109	0.00109	CcSEcCtD
Oritavancin—Rash—Methotrexate—systemic lupus erythematosus	0.00108	0.00108	CcSEcCtD
Oritavancin—Dermatitis—Methotrexate—systemic lupus erythematosus	0.00108	0.00108	CcSEcCtD
Oritavancin—Headache—Methotrexate—systemic lupus erythematosus	0.00108	0.00108	CcSEcCtD
Oritavancin—Nausea—Methotrexate—systemic lupus erythematosus	0.00102	0.00102	CcSEcCtD
